MedTech Dive June 7, 2024
Abbott sees the device as a product that can help its rhythm management business grow 6% to 7%.
Dive Brief:
- Abbott said Thursday it has received a CE mark for its dual-chamber leadless pacemaker, clearing the company to start selling the system in Europe.
- The Aveir DR system has two synchronized leadless pacemakers, one for the right atrium and another for the right ventricle, setting it apart from single-chamber devices such as Medtronic’s Micra.
- Abbott has identified the device, which won approval in the U.S. in 2023, as a product that can help its cardiac rhythm management business achieve sales growth of at least around 6% to 7%.
Dive Insight:
Abbott named Aveir as a driver of the...
Today's Sponsors
Today's Sponsor
Topics: Medical Devices